Aktis Oncology, Inc. Shareholders' Equity
Aktis Oncology, Inc. (AKTS) had Shareholders' Equity of $484.84 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent $484.84M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $506.11M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$146.15M.
- 2025-06-30: Stockholders' Equity Attributable to Parent -$118.20M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $484.84M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $506.11M 10-Q · filed 2026-08-13 |
| 2025-12-31 | -$146.15M 10-Q · filed 2026-08-13 |
| 2025-06-30 | -$118.20M 10-Q · filed 2026-08-13 |
| 2025-03-31 | -$101.56M 10-Q · filed 2026-08-13 |
| 2024-12-31 | -$87.80M 10-Q · filed 2026-08-13 |